STXS Stock Tumbles Despite EMAGIN Catheter Submission for Approval

Stereotaxis (STXS) recently submitted an application seeking FDA regulatory clearance for its EMAGIN 5F catheter, marking a major step in expanding its Robotic Magnetic Navigation (RMN) technology into endovascular procedures.With this submission, Stereotaxis aims to revolutionize the endovascular field by bringing robotics into neurointerventional, cardiology, and radiology procedures. The company expects regulatory approval in the second half of 2025, positioning itself as a multi-specialty robotics leade ...